Prognostic significance of CD95, P53, and BCL2 expression in extranodal non-Hodgkin's lymphoma

Annals of Hematology

Volumn 89, Issue 9, 2010, Pages 889-896

  Chatzitolios, Anastasios ^a   Venizelos, Ioannis ^a   Tripsiannis, Gregory ^b   Anastassopoulos, George ^b   Papadopoulos, Nikolaos ^b  

^a Ippokration Hospital   (Greece)

^b DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

Author keywords

BCL2; CD95; DLBCL; Extranodal non Hodgkin's lymphoma; MALTL; P53; Prognostic significance

Indexed keywords

FAS ANTIGEN; PROTEIN BCL 2; PROTEIN P53;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER SURVIVAL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SURVIVAL RATE; SURVIVAL TIME; TUMOR LOCALIZATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD95; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYMPHOMA, B-CELL, MARGINAL ZONE; LYMPHOMA, LARGE B-CELL, DIFFUSE; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-BCL-2; SURVIVAL RATE; TUMOR SUPPRESSOR PROTEIN P53; YOUNG ADULT;

EID: 77955658117     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-010-0945-x     Document Type: Article

References (26)

1. Feller AC, Diebold J (2004) Histopathology of nodal and extranodal non-Hodgkin's lymphomas. 3rd, completely rev. and updated ed. Springer, Berlin, p 186
2. M Irisarri J Plumas T Bonnefoix, et al. 2000 Resistance to CD95-mediated apoptosis through constitutive c-FLIP expression in a non-Hodgkin's lymphoma B cell line Leukemia 14 2149 2158 10.1038/sj.leu.2401954 1:CAS:528: DC%2BD3MXmtVagtA%3D%3D 11187905 (Pubitemid 32042255)
3. A Troeger L Glouchkova G Escherich, et al. 2008 Reduced expression of defective modulation of TNF receptor/ligand family molecules on proB-ALL blasts Klin Pediatr 220 353 357 10.1055/s-0028-1086028 1:STN:280:DC%2BD1cnosVaisA%3D%3D
4. TS Griffith X Yu JM Herndon DR Green TA Ferguson 1996 CD95-induced apoptosis of lymphocytes in an immune-privileged cite induces immunological tolerance Immunity 5 7 16 10.1016/S1074-7613(00)80305-2 1:CAS:528: DyaK28Xks1Omtbw%3D 8758890 (Pubitemid 26254781)
5. TH Landowski L Moscinski R Burke 2001 CD95 antigen mutations in hematopoietic malignancies (review) Leuk Lymphoma 42 835 846 10.3109/10428190109097702 1:CAS:528:DC%2BD3MXntVSgtLc%3D 11697638
6. WH Wilson J Teruya-Feldstein T Fest 1997 Relationship of P53, BCL2, and tumor proliferation to clinical drug resistance in non-Hodgkin's lymphomas Blood 89 601 609 1:CAS:528:DyaK2sXlt1Cnuw%3D%3D 9002964
7. SL Harris AJ Levine 2005 The P53 pathway: positive and negative feedback loops (review) Oncogene 24 2899 2908 10.1038/sj.onc.1208615 1:CAS:528: DC%2BD2MXjtlehs7c%3D 15838523 (Pubitemid 40638098)
8. RJ Steele DP Lane 2005 P53 in cancer: a paradigm for modern management of cancer (review) Surg 3 197 205 10.1016/S1479-666X(05)80041-1 1:STN:280:DC%2BD2Mvht1ejsQ%3D%3D
9. G Kroemer 1997 The proto-oncogene BCL2 and its role in regulating apoptosis Nat Med 3 614 620 10.1038/nm0697-614 1:CAS:528:DyaK2sXjsFOisbs%3D 9176486 (Pubitemid 27264969)
10. DT Chao SJ Korsmeyer 1998 BCL-2 family: regulators of cell death Annu Rev Immunol 16 395 419 10.1146/annurev.immunol.16.1.395 1:CAS:528: DyaK1cXislyntLs%3D 9597135 (Pubitemid 28183370)
11. F Pazella H Turley I Kuzu MF Tungekar MS Dunnill CB Pierce, et al. 1993 BCL2 protein in non-small-cell lung carcinoma N Engl J Med 329 690 694 10.1056/NEJM199309023291003 (Pubitemid 23252262)
12. F Pazella K Gatter 1995 What is the value of BCL2 protein detection for histopathologists? Histopathology 26 89 93 10.1111/j.1365-2559.1995.tb00628.x
13. S Wohlfart D Sebinger P Gruber 2004 FAS (CD95) mutations are rare in gastric MALT lymphoma but occur more frequently in primary gastric diffuse large B-cell lymphomas DLBCL Am J Pathol 164 1081 1089 1:CAS:528:DC%2BD2cXitl2jtLw%3D 14982861
14. J Imamura I Miyoshi HP Koeffler 1994 P53 in hematologic malignancies Blood 84 2412 2421 1:CAS:528:DyaK2cXmsFalsLY%3D 7919360
15. L Hernandez T Fest M Cazorla, et al. 1996 P53 gene mutations and protein overexpression are associated with aggressive variants of mantle cell lymphomas Blood 87 3351 3359 1:CAS:528:DyaK28Xit1Krs7c%3D 8605352
16. Y Li AJ Raffo L Drew Y Mao 2003 FAS-mediated apoptosis is dependent on wild-type P53 status in human cancer cells expressing a temperature-sensitive P53 mutant alanine-143 Cancer Res 63 1527 1533 1:CAS:528:DC%2BD3sXisFait78%3D 12670900
17. GC Das D Holiday R Gallardo C Haas 2001 Taxol-induced cell cycle arrest and apoptosis: dose-response relationship in lung cancer cells of different wild-type P53 status and under isogenic condition Cancer Lett 165 147 153 10.1016/S0304-3835(01)00404-9 1:CAS:528:DC%2BD3MXitF2ru70%3D 11275363 (Pubitemid 32244171)
18. ZA Stewart LJ Tang JA Pietenpol 2001 Increased P53 phosphorylation after microtubule disruption is mediated in a microtubule inhibitor- and cell-specific manner Oncogene 20 113 124 10.1038/sj.onc.1204060 1:CAS:528: DC%2BD3MXhtFChtr0%3D 11244509 (Pubitemid 32142344)
19. G Makin JA Hickman 2000 Apoptosis and cancer chemotherapy Cell Tissue Res 301 143 152 10.1007/s004419900160 1:CAS:528:DC%2BD3cXlsFGns7o%3D 10928287
20. MA Piris F Pezella JC Martinez-Montero, et al. 1994 P53 and BCL2 expression in high-grade B-cell lymphomas: correlation with survival time Br J Cancer 69 337 341 1:STN:280:DyaK2c7ivVGgsg%3D%3D 8297731
21. JC Reed 1995 Regulation of apoptosis by BCL2 family proteins and its role in cancer and chemoresistance Curr Opin Oncol 7 541 546 10.1097/00001622- 199511000-00012 1:CAS:528:DyaK28XisFylsrs%3D 8547403
22. O Hermine C Haioun E Lepage 1996 Prognostic significance of BCL2 protein expression in aggressive non-Hodgkin's lymphoma. Groupe d'Etude des Lymphomes de l'Adulte (GELA) Blood 87 265 272 1:CAS:528:DyaK28Xit1SitQ%3D%3D 8547651
23. T Miyashita JC Reed 1993 BCL2 oncoprotein blocks chemotherapyinduced apoptosis in a human leukemia cell line Blood 81 151 157 1:CAS:528: DyaK3sXhtl2gt70%3D 8417786
24. K Iwai T Miyawaki T Takizawa 1994 Differential expression of BCL2 and susceptibility to anti-Fas-mediated cell death in peripheral blood lymphocytes, monocytes, and neutrophils Blood 84 1201 1208 1:CAS:528:DyaK2cXlslOmurk%3D 7519477
25. T Yoshino E Kondo L Cao 1994 Inverse expression of BCL2 protein and FAS antigen in lympho-blasts in peripheral blood T and B lymphocytes Blood 83 1856 1861 1:CAS:528:DyaK2cXisVajsrY%3D 7511441
26. PL Nguyen NL Harris J Ritz MJ Robertson 1996 Expression of CD95 antigen and BCL2 protein in non Hodgkin's lymphomas and Hodgkin's disease Am J Pathol 148 847 853 1:STN:280:DyaK28zntVansQ%3D%3D 8774139